Free Trial
NASDAQ:DRIO

DarioHealth (DRIO) Stock Price, News & Analysis

DarioHealth logo
$0.55 -0.02 (-4.03%)
Closing price 08/1/2025 03:56 PM Eastern
Extended Trading
$0.54 -0.01 (-1.62%)
As of 08/1/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About DarioHealth Stock (NASDAQ:DRIO)

Key Stats

Today's Range
$0.53
$0.59
50-Day Range
$0.55
$0.72
52-Week Range
$0.50
$1.55
Volume
116,368 shs
Average Volume
173,314 shs
Market Capitalization
$24.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Moderate Buy

Company Overview

DarioHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

DRIO MarketRank™: 

DarioHealth scored higher than 37% of companies evaluated by MarketBeat, and ranked 704th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    DarioHealth has only been the subject of 1 research reports in the past 90 days.

  • Read more about DarioHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DarioHealth is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DarioHealth is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DarioHealth has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DarioHealth's valuation and earnings.
  • Percentage of Shares Shorted

    6.66% of the outstanding shares of DarioHealth have been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently decreased by 4.52%, indicating that investor sentiment is improving.
  • Dividend Yield

    DarioHealth does not currently pay a dividend.

  • Dividend Growth

    DarioHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.66% of the outstanding shares of DarioHealth have been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently decreased by 4.52%, indicating that investor sentiment is improving.
    • Insider Buying vs. Insider Selling

      In the past three months, DarioHealth insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 33.39% of the stock of DarioHealth is held by institutions.

    • Read more about DarioHealth's insider trading history.
    Receive DRIO Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

    DRIO Stock News Headlines

    New Federal Land Rush About to Start?
    A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being quietly opened to the public, and former hedge fund firm manager Whitney Tilson believes this is the best chance in years to turn a small stake into huge gains. He's naming one $10 stock leading this "US: IPO" boom.
    See More Headlines

    DRIO Stock Analysis - Frequently Asked Questions

    DarioHealth's stock was trading at $0.7861 at the beginning of the year. Since then, DRIO shares have decreased by 30.0% and is now trading at $0.5499.

    DarioHealth Corp. (NASDAQ:DRIO) posted its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.07. The firm earned $6.75 million during the quarter, compared to analyst estimates of $7.48 million. DarioHealth had a negative net margin of 159.80% and a negative trailing twelve-month return on equity of 65.81%.
    Read the conference call transcript
    .

    The following companies are subsidiaries of DarioHealth: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc..

    Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA).

    Company Calendar

    Last Earnings
    5/14/2025
    Today
    8/02/2025
    Next Earnings (Estimated)
    8/06/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:DRIO
    CIK
    1533998
    Employees
    200
    Year Founded
    2011

    Price Target and Rating

    High Price Target
    $3.00
    Low Price Target
    $1.00
    Potential Upside/Downside
    +263.7%
    Consensus Rating
    Moderate Buy
    Rating Score (0-4)
    2.67
    Research Coverage
    3 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($0.56)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$42.75 million
    Net Margins
    -159.80%
    Pretax Margin
    -159.22%
    Return on Equity
    -65.81%
    Return on Assets
    -38.41%

    Debt

    Debt-to-Equity Ratio
    0.26
    Current Ratio
    2.01
    Quick Ratio
    1.77

    Sales & Book Value

    Annual Sales
    $27.04 million
    Price / Sales
    0.90
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $2.11 per share
    Price / Book
    0.26

    Miscellaneous

    Outstanding Shares
    44,460,000
    Free Float
    39,484,000
    Market Cap
    $24.45 million
    Optionable
    Optionable
    Beta
    1.24

    Social Links

    Elon Musk's Next Move Cover

    Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

    Get This Free Report

    This page (NASDAQ:DRIO) was last updated on 8/3/2025 by MarketBeat.com Staff
    From Our Partners